Potiga

Potiga is a once-daily medication used to treat epilepsy in children and adults. It is an antiepileptic drug that contains the active ingredient leviracetam. The medication is available in various strengths and forms, including a solution and a tablet.

The primary use of Potiga is to treat partial-onset seizures, which are seizures that affect only one part of the brain. It can also be used as an adjunct therapy to treat primary generalized tonic-clonic seizures and tonic seizures.

In clinical trials, Potiga was found to be effective in reducing the frequency of seizures in patients with partial-onset seizures. The medication works by reducing the abnormal electrical activity in the brain that causes seizures.

The dosage of Potiga is adjusted individually for each patient, based on their age, weight, and the severity of their seizures. The typical starting dose for adults and children over 16 is 50-100 mg per day, which can be titrated up to a maximum daily dose of 2600 mg.

Common side effects of Potiga include dizziness, headache, fatigue, and sleepiness. In rare cases, the medication can cause more serious side effects, such as visual disturbances, cognitive dysfunction, and behavioral changes.

Potiga is contraindicated in patients with a history of suicidal thoughts or behavior, and caution should be exercised when prescribing the medication to patients with a history of depression or other psychiatric conditions. As with all medications, Potiga should be used under the supervision of a qualified healthcare professional.